Uniti Group Inc. to Participate at the Deutsche Bank 32nd Annual Media, Internet & Telecom Conference
LITTLE ROCK, Ark., March 05, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Senior […]
FreightCar America, Inc. To Release Fourth Quarter and Full Year 2023 Results On March 18, 2024
CHICAGO, March 05, 2024 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL), a diversified manufacturer of railroad freight cars, today […]
ThredUp to Participate in Morgan Stanley Conference
OAKLAND, Calif., March 05, 2024 (GLOBE NEWSWIRE) — ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms […]
Cricut, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Delivered 7th consecutive year of profitability with net income of $53.6 million, or 7.0% margin Generated $288.1 million in Cash […]
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
— Preliminary data from Phase 2 portion of Phase 2/3 study evaluating GRANITE, Gritstone’s personalized cancer vaccine in front-line metastatic, […]
89bio to Participate in the Leerink Partners Global Biopharma Conference
SAN FRANCISCO, March 05, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development […]
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical […]
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced […]
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsExpect to report DREAM U.S. pivotal study efficacy and […]
HashiCorp Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Fourth quarter revenue totaled $155.8 million, representing an increase of 15% year-over-year; fiscal 2024 revenue totaled $583.1 million, representing an […]
